Surgeons in US perform worldâs first human bladder transplant on a man
HQ Team May 19, 2025: US surgeons have performed the worldâs first successful human bladder transplant on a 41-year-old patient who lost most.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team May 19, 2025: US surgeons have performed the worldâs first successful human bladder transplant on a 41-year-old patient who lost most.
HQ Team May 19, 2025: More than one in four cars sold worldwide is set to be electric this year, as the growth.
HQ Team May 19, 2025: The UKâs Medicines and Healthcare products Regulatory Agency has approved Janssen-Cilag Limitedâs guselkumab (Tremfya) to treat Crohnâs disease.
HQ Team May 19, 2025: The UK and Wellcome Trust will invest ÂŁ600 million to create a new health data research service to.
HQ Team May 19, 2025: US President Donald Trumpâs plan to raise taxes on private philanthropic foundations will harm charities’ efforts to provide.
HQ Team May 18, 2025: The US Food and Drug Administration has granted marketing access to Fujirebio Diagnostics, Inc.âs blood test to diagnose.
HQ Team May 16, 2025: The world is losing its battle against hunger. The latest Global Report on Food Crises reveals a sixth consecutive year.
HQ Team May 16, 2025: Dengue fever has become a serious and growing health threat in India, especially between July and mid-November. Recent.
HQ Team May 14, 2025: The US regulator is initiating action to remove concentrated ingestible fluoride prescription drug products for children from the.
HQ Team May 15, 2025: A recent meta research by Dr Salvatore Cortellino and Professor Antonio Giordano, President of the Sbarro Health Research Organization (SHRO) and molecular oncologist.